Company Continues to Pursue Review of Strategic AlternativesWOBURN, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: NURO) today reported financial and business highlights for the quarter and nine ...
Good day and welcome to the Vertex Pharmaceuticals third-quarter 2024 earnings call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to ...
Q3 2024 Earnings Call Transcript November 4, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.38, expectations were $4.14. Operator: Good day. And welcome to ...
See expanded profiles for more than 2,000 programs. Unlock entering class stats including MCAT, GMAT and GRE scores for business, medicine, engineering, education and nursing programs.